NFON (NFN) Q1 2025 earnings summary
Event summary combining transcript, slides, and related documents.
Q1 2025 earnings summary
26 Nov, 2025Executive summary
Launched NFON Next 2027 strategy and dedicated AI sales team, introducing AI-powered products such as voicemail transcription and Nia, an AI assistant, to drive customer acquisition and operational efficiency.
Achieved 4.0% year-over-year revenue growth in Q1 2025, driven by botario contribution, price adjustments, and premium solutions expansion.
Recurring revenue accounted for 93.9% of total revenue, up from 93.6% in Q1 2024, with low churn stabilizing recurring revenue.
Number of seats grew 0.4% year-over-year to 661,350, with slower growth due to longer lead cycles and DTS migration focus.
Early positive sales outcomes and increased engagement rates from AI initiatives, with over 60 leads and 30 demos in Q1.
Financial highlights
Q1 2025 revenue rose 4.0% year-over-year to EUR 22.1 million, with botario contributing over 90% of total revenue growth.
Adjusted EBITDA declined 6.9% to EUR 2.6 million, reflecting higher investment in AI, personnel, and one-off effects.
Gross margin improved to 86% (from 84.1%), driven by high-margin recurring revenues and botario's contribution.
Net result declined to EUR 0.2 million (Q1 2024: EUR 0.5 million) due to higher OpEx and interest expenses from the botario acquisition.
Free cash flow rose to EUR 1.1 million, and cash position increased to EUR 13.6 million.
Outlook and guidance
Revenue expected to grow 8–10% in 2025, supported by price increases and botario's momentum.
Adjusted EBITDA guidance for 2025 set at EUR 13.5–15.5 million, with a margin above 15%.
Midterm (2027) targets: double-digit revenue growth and adjusted EBITDA margin above 15%.
Profitability expected to be backloaded, with 60% of EBITDA contribution in H2.
Further price adjustments planned for Q2 2025 to strengthen revenue base.
Latest events from NFON
- Stable 2025 growth driven by AI solutions, with revenue up 2.0% and EBITDA up 2.4%.NFN
Q4 2025 TU26 Feb 2026 - Recurring revenue at 94.3% and EBITDA up 50.9%, with botario acquisition fueling growth.NFN
Q3 202413 Feb 2026 - Adjusted EBITDA up 62.3% to €5.5m, recurring revenue share at 94.3% in H1 2024.NFN
Q2 202423 Jan 2026 - AI-led strategy and Botario integration drive strong growth, margin gains, and 2025 optimism.NFN
H2 202428 Nov 2025 - 2025 guidance lowered amid slower core growth, but AI and partner programs drive optimism.NFN
Q2 202523 Nov 2025 - Revenue up 2.7% to €66M, adjusted EBITDA down 3.5%, seat base fell 2.6%.NFN
Q3 202520 Nov 2025 - NFON targets double-digit growth by 2027 through AI innovation, partnerships, and acquisitions.NFN
CMD 202413 Jun 2025 - Strong earnings, cash flow, and AI-driven growth position NFON for accelerated 2025 expansion.NFN
Q4 2024 TU6 Jun 2025